The Johns Hopkins University
Baltimore, Maryland, 21287, United States
NCT Number: NCT06106451
In this study, the investigators will evaluate the feasibility and potential efficacy of programs to improve functional outcomes after minimally-invasive transcatheter aortic valve replacement (TAVR). The investigators will examine the potential efficacy of (a) a motivation interviewing program, and (b) a home-based physical activity + motivational interviewing program, compared to (c) usual care + enhanced education in patients post-TAVR procedure.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Not applicable
Baltimore, Maryland, 21287, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients in this arm will receive a pamphlet explaining the benefits of cardiac rehabilitation. This pamphlet will be given in addition to standard of care patient education. The research team will also call the patient at four specified time points to provide additional information.
Patients in this arm of the study will participate in a tailor-made motivational interviewing program. These motivational interviewing sessions will focus on enhancing communication with patients. Each motivational interviewing session will be approximately one hour long. There will be a total of 4-6 motivational interviewing sessions.
Patients in this arm will be evaluated on postoperative day 1 by a physical therapist on the study team. After the evaluation, the physical therapist will use the information from the evaluation to make a tailored home-based physical activity program for the patient. The patient will begin the home-based physical activity program on the day of their 1-month post-operative cardiology clinic appointment. In addition to the home-based activity program, patients will participate in a tailor-made motivational interviewing program. These motivational interviewing sessions will focus on enhancing communication with patients. Each motivational interviewing session will be approximately one hour long. There will be a total of 4-6 motivational interviewing sessions.
Time frame: Approximately 20 weeks after the day of the TAVR procedure
This outcome will measure the number of motivational interviewing sessions in which the patient participates. Motivational Interviewing Arm Outcome.
Time frame: Approximately 20 weeks after the day of the TAVR procedure
This outcome will measure the number of home-based activity sessions the patient logs. Home-based Activity Arm
Time frame: Approximately 20 weeks after the day of the TAVR procedure
This outcome will measure the number of cardiac rehabilitation sessions attended by the participant.
Time frame: Approximately 20 weeks after the day of the TAVR procedure
This outcome will measure any self-reported barriers that patients experience to participating in cardiac rehabilitation sessions.
Time frame: Approximately 20 weeks after the day of the TAVR procedure
This survey is a standardized measure of health status. This survey is scored in two separate sections. The first section measures the five dimensions mobility, self-care, usual activities, pain/discomfort and anxiety/depression. The first section is measured by a minimum score of 5 and a maximum score of 25. Higher score greater level of problems. The second section measures self report health status on a 0 to 100. Higher score best health.
Time frame: 20 weeks after the day of the TAVR procedure
The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a survey used to measure health status in patients with heart failure. The KCCQ scores four domains and one summary score. The four domains are physical limitations score, symptom frequency score, quality of life score, and the social limitations score. These five scores are scaled on a scale of 0 to 100. Higher score better health status.
Time frame: Approximately 20 weeks after the day of the TAVR procedure
This survey measures disability due to health conditions including diseases, illnesses, injuries, mental or emotional problems, and problems with alcohol and drugs. This survey has a minimum score of 12 and a maximum score of 60. Higher scores more disability.
Time frame: 20 weeks after the day of the TAVR procedure
This survey is a self-reported measure of potential depression in older adults. The minimum score for this survey is 0 and the maximum score is 15. A score of 5 or greater suggests depression.
Time frame: Approximately 20 weeks after the day of the TAVR procedure
Any events adverse events or serious adverse events that occur while the patient is participating in the study.
Time frame: Approximately 20 weeks after the day of the TAVR procedure
This test measures the number of steps the patient can take in 2 minutes time. The number of steps recorded is compared to a standardized range of steps based on age.
Time frame: Approximately 20 weeks after the day of the TAVR procedure
This test records the number of stands from sitting the patient can complete in 30 seconds time. The number of stands the patient can complete is compared to the average number is compared to the average number in the patient's age group.
Time frame: Approximately 20 weeks after the day of the TAVR procedure
This outcome will measure the length of each motivational interviewing session attended.
Time frame: Approximately 20 weeks after the day of the TAVR procedure
Patient satisfaction will be measured using a Likert scale from 1 to 5. 1 indicates the patient is very dissatisfied. 5 indicates the patient is very satisfied.
Time frame: Approximately 20 weeks after the day of the TAVR procedure
This outcome measure the number of times the patient has contact with the study physical therapy.
Time frame: Approximately 20 weeks after the day of the TAVR procedure
This outcome will measure activity (e.g. number of steps taken) while wearing the Fitbit during periods of valid wear.
Johns Hopkins University
Other
Acronym: OPTIMAL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05295628
Aortic Valve Disease, Aortic Valve Insufficiency
Chandler, Arizona, United States
View Trial DetailsNCT00465218
Aortic Valve Disease, Brain Diseases
Ottawa, Ontario, Canada
View Trial DetailsNCT04909424
Aortic Valve Disease, Cardiovascular Diseases
Toulouse, France
View Trial DetailsNCT01194362
Aortic Valve Disease, Cardiovascular Diseases
Plano, Texas, United States
View Trial Details